Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor

被引：0
|
作者：
Victor Farutin
Thomas Prod’homme
Kevin McConnell
Nathaniel Washburn
Patrick Halvey
Carol J. Etzel
Jamey Guess
Jay Duffner
Kristen Getchell
Robin Meccariello
Bryan Gutierrez
Christopher Honan
Ganlin Zhao
Nicholas A. Cilfone
Nur Sibel Gunay
Jan L. Hillson
David S. DeLuca
Katherine C. Saunders
Dimitrios A. Pappas
Jeffrey D. Greenberg
Joel M. Kremer
Anthony M. Manning
Leona E. Ling
Ishan Capila
机构：
[1] Momenta Pharmaceuticals Inc.,Department of Medicine, Division of Rheumatology
[2] Corrona LLC,undefined
[3] DeLuca Data Science,undefined
[4] Columbia University School of Medicine,undefined
[5] New York University School of Medicine,undefined
[6] Albany Medical College,undefined
来源：
Arthritis Research & Therapy | / 21卷
关键词：
Rheumatoid arthritis; TNF inhibitors; Treatment response; Innate immune system; Adaptive immune system; RNA-seq; Whole blood; Gene expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Anti-tumor necrosis factor-α monoclonal antibody therapy for rheumatoid arthritis.
    Mugnier, B
    Bouvenot, G
    REVUE DE MEDECINE INTERNE, 2000, 21 (10): : 854 - 862
  • [32] Anti-Tumor Necrosis Factor Alpha Therapy and Periodontal Inflammation in Rheumatoid Arthritis A clinical and biochemical approach
    Ancuta, Codrina
    Ancuta, Eugen
    Chirieac, Rodica
    Antohe, Magda
    Iordache, Cristina
    REVISTA DE CHIMIE, 2017, 68 (02): : 369 - 372
  • [33] Transcriptional profiling of leukocytes from rheumatoid arthritis patients before and after anti-tumor necrosis factor therapy: A comparison of anti-nuclear antibody positive and negative subsets
    Davis, Laurie S.
    Reimold, Andreas M.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (05) : 2183 - 2192
  • [34] Strategies after the failure of the first anti-tumor necrosis factor α agent in rheumatoid arthritis
    Papagoras, Charalampos
    Voulgari, Paraskevi V.
    Drosos, Alexandros A.
    AUTOIMMUNITY REVIEWS, 2010, 9 (08) : 574 - 582
  • [35] Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis
    Marcora, Samuele M.
    Chester, Kathryn R.
    Mittal, Gayatri
    Lemmey, Andrew B.
    Maddison, Peter J.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 84 (06) : 1463 - 1472
  • [36] Scoring evaluation for histopathological features of synovium in patients with rheumatoid arthritis during anti-tumor necrosis factor therapy
    Hajime Yamanaka
    Ken-ichiro Goto
    Kazutoshi Miyamoto
    Rheumatology International, 2010, 30 : 409 - 413
  • [37] Combination therapy of the chimeric monoclonal anti-tumor necrosis factor α antibody (infliximab) with methotrexate in patients with rheumatoid arthritis
    Antoni, C
    Kalden, JR
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : S73 - S77
  • [38] The effect of anti-tumor necrosis factor (TNF)-alpha therapy with etanercept on endothelial functions in patients with rheumatoid arthritis
    Tikiz, Hakan
    Arslan, Oezlem
    Pirildar, Timur
    Tikiz, Canan
    Bayindir, Petek
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2010, 10 (02) : 98 - 103
  • [39] Obesity and Remission Rates in Japanese Patients With Rheumatoid Arthritis Requiring Anti-Tumor Necrosis Factor Alpha Therapy
    Yamazaki, Kenji
    Suzuki, Etsuji
    Ishihara, Ryuhei
    Miyamoto, Toshiaki
    ARCHIVES OF RHEUMATOLOGY, 2020, 35 (04) : 600 - 608
  • [40] Scoring evaluation for histopathological features of synovium in patients with rheumatoid arthritis during anti-tumor necrosis factor therapy
    Yamanaka, Hajime
    Goto, Ken-ichiro
    Miyamoto, Kazutoshi
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (03) : 409 - 413
12345